Furthermore, we confirmed that H3K4me1 and H3K4me2 were impacted by DNMT1-depletion via gDEC, and we observed a consistent increase in H3K4me1 and H3K4me2 concurrent with growth inhibition in all three prostate cancer models evaluated. This evidence concerns the gene DNMT1 and prostate carcinoma.